CONMED Corporation

NYSE:CNMD

75.4 (USD) • At close September 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995199419931992199119901989198819871986
Revenue 1,240.9541,045.4721,010.635862.459955.097859.634796.392763.52719.168734.467756.755767.14725.077713.723694.739742.183694.288646.812617.305558.388497.13453.062428.722392.23372.6336.4138.3125.699.671.153.642.638.531.419.914.212.510.5
Cost of Revenue 597.887474.227442.599402.159430.382390.524365.351355.19337.466335.998350.287361.297350.143348.339357.407359.802345.163333.966304.284271.496237.433215.891204.374158.736152.814667.25947.434.926.920.318.415.311.77.56.45.5
Gross Profit 643.067571.245568.036460.3524.715469.11431.041408.33381.702398.469406.468405.843374.934365.384337.332382.381349.125312.846313.021286.892259.697237.171224.348233.494219.8190.471.166.652.236.226.722.320.116.18.26.76.15
Gross Profit Ratio 0.5180.5460.5620.5340.5490.5460.5410.5350.5310.5430.5370.5290.5170.5120.4860.5150.5030.4840.5070.5140.5220.5230.5230.5950.590.5660.5140.530.5240.5090.4980.5230.5220.5130.4120.4720.4880.476
Reseach & Development Expenses 52.60247.15243.56540.47345.4642.18832.30732.25427.43627.77925.83128.21428.65129.65231.83733.10830.430.71525.46920.20517.30616.08714.8314.8712.112332.82.400000000
General & Administrative Expenses 0000400.141355.617351.799338.4303.091293.942310.73302.469277.707276.463266.31272.437240.541234.832216.685183.183157.453141.735140.56124.673107.293.635.331.625.62125.314.311.910.16.953.93.3
Selling & Marketing Expenses 00000000000000000000000000000000000000
SG&A 459.679454.039414.754373.817400.141355.617351.799338.4303.091293.942310.73302.469277.707276.463266.31272.437240.541234.832216.685183.183157.453141.735140.56124.673107.293.635.331.625.62125.314.311.910.16.953.93.3
Other Expenses 0-112.011-1.127-0.355-5.18800-2.94207.328.757.20102.17610.9161.577-4.62951.9027.11920.343-2.9170029.48725.723.676.403.93.32.22.11.610.60.40.3
Operating Expenses 512.281501.191458.319414.29445.601397.805384.106370.654330.527345.683349.96340.633306.358308.291309.063307.122266.312317.449249.273223.731171.842157.822155.39169.03145129.245.34133.427.328.616.51411.77.95.64.33.6
Operating Income 130.78670.05437.847-26.971.60371.30546.93537.67651.17552.78656.50865.218.27457.09328.26975.25980.991-4.60363.74863.16179.95579.34968.95864.46474.861.225.825.618.88.9-1.95.86.14.40.31.11.81.4
Operating Income Ratio 0.1050.0670.037-0.0310.0020.0830.0590.0490.0710.0720.0750.0850.0110.080.0410.1010.117-0.0070.1030.1130.1610.1750.1610.1640.2010.1820.1870.2040.1890.125-0.0350.1360.1580.140.0150.0770.1440.133
Total Other Income Expenses Net -49.958-140.91635.25828.57329.622-20.652-18.203-2.942-6.031-16.642-0.263-2.749-64.205-4.323-3.0284.3762.807-52.58-7.119-21.168-13.061-24.513-30.824-34.286-32.3-30.9-36.4-0.1-2-0.6-0.20.30.3-0.70.10.20.1-0.2
Income Before Tax 80.828-70.86273.1051.60331.22550.65328.73219.37545.14446.67550.63259.48-2.30545.65718.15569.26364.757-24.40148.1749.56253.00954.83638.13430.17842.530.3-10.725.516.88.3-2.16.15.93.70.21.21.81.2
Income Before Tax Ratio 0.065-0.0680.0720.0020.0330.0590.0360.0250.0630.0640.0670.078-0.0030.0640.0260.0930.093-0.0380.0780.0890.1070.1210.0890.0770.1140.09-0.0770.2030.1690.117-0.0390.1430.1530.1180.010.0850.1440.114
Income Tax Expense 16.3699.7210.563-7.9142.6059.799-26.7554.71114.64614.48314.69318.999-3.05715.3116.01824.70223.301-11.89416.17616.09720.92719.74113.72810.86415.310.9-3.69.25.92.9-0.7221.30.10.40.70.5
Net Income 64.459-80.58262.5429.51728.6240.85455.48714.66430.49832.19235.93940.4810.75230.34612.13744.56141.456-12.50731.99433.46532.08234.15124.40619.31427.217.8-7.116.310.95.4-1.44.13.92.4-0.30.81.10.7
Net Income Ratio 0.052-0.0770.0620.0110.030.0480.070.0190.0420.0440.0470.0530.0010.0430.0170.060.06-0.0190.0520.060.0650.0750.0570.0490.0730.053-0.0510.130.1090.076-0.0260.0960.1010.076-0.0150.0560.0880.067
EPS 2.1-2.682.140.331.011.451.990.531.11.171.31.430.0271.060.421.551.46-0.451.091.131.111.251.020.841.190.79-0.310.770.640.4-0.110.280.310.25-0.0270.080.140.1
EPS Diluted 2.04-2.681.940.320.971.411.970.521.091.161.281.410.0261.050.421.521.43-0.451.081.111.11.2310.831.170.77-0.310.750.630.37-0.110.280.310.25-0.0270.080.140.1
EBITDA 182.186-41.957108.5945.65573.92671.30546.93590.04395.05498.52104.375111.826111.26398.969.552107.595111.5477.828101.653111.197125.77101.71999.10693.951100.584.869.23223.812.81.67.77.961.21.52.11.7
EBITDA Ratio 0.147-0.040.1070.0530.0770.0830.0590.1180.1320.1340.1380.1460.1530.1390.10.1450.1610.120.1650.1990.2530.2250.2310.240.270.2520.50.2550.2390.180.030.1810.2050.1910.060.1060.1680.162